Come up with a name for your new list and we'll add to it:
APT Therapeutics raised a round of funding on , . Investors include
Nidus Center for Scientific Enterprise.
APT Therapeutics develops acute-use drugs for controlling clot formation in stroke, pulmonary embolism, myocardial infarction, deep vein thrombosis, and transplantation.…